| __timestamp | Bio-Techne Corporation | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 106352000 | 2395000 |
| Thursday, January 1, 2015 | 144969000 | 9057000 |
| Friday, January 1, 2016 | 162364000 | 393000 |
| Sunday, January 1, 2017 | 188462000 | 79309000 |
| Monday, January 1, 2018 | 210850000 | 134428000 |
| Tuesday, January 1, 2019 | 240515000 | 175431000 |
| Wednesday, January 1, 2020 | 255497000 | 124165000 |
| Friday, January 1, 2021 | 298182000 | 121875000 |
| Saturday, January 1, 2022 | 349103000 | 10114000 |
| Sunday, January 1, 2023 | 366887000 | 9206000 |
| Monday, January 1, 2024 | 389335000 |
Igniting the spark of knowledge
In the ever-evolving biotech industry, understanding cost structures is crucial for investors and stakeholders. Bio-Techne Corporation and Wave Life Sciences Ltd. offer a fascinating comparison in their cost of revenue trends from 2014 to 2023. Bio-Techne, a leader in the sector, has seen its cost of revenue grow steadily, peaking at nearly 390% of its 2014 value by 2023. This growth reflects its expanding operations and market reach. In contrast, Wave Life Sciences, a smaller player, experienced a more volatile trajectory. After a significant spike in 2017, its costs fluctuated, highlighting the challenges faced by emerging biotech firms. Notably, data for 2024 is missing for Wave Life Sciences, indicating potential reporting gaps or strategic shifts. This comparison underscores the diverse financial landscapes within the biotech industry, offering insights into operational efficiencies and market strategies.
Cost Insights: Breaking Down Eli Lilly and Company and Bio-Techne Corporation's Expenses
Cost Insights: Breaking Down Merck & Co., Inc. and Bio-Techne Corporation's Expenses
Analyzing Cost of Revenue: Neurocrine Biosciences, Inc. and Wave Life Sciences Ltd.
Cost of Revenue Comparison: Bio-Techne Corporation vs Grifols, S.A.
Comparing Cost of Revenue Efficiency: Bio-Techne Corporation vs Bausch Health Companies Inc.
Cost of Revenue Comparison: BioMarin Pharmaceutical Inc. vs Wave Life Sciences Ltd.
Cost Insights: Breaking Down Lantheus Holdings, Inc. and Wave Life Sciences Ltd.'s Expenses
ADMA Biologics, Inc. vs Wave Life Sciences Ltd.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: CRISPR Therapeutics AG vs Wave Life Sciences Ltd.
Cost of Revenue Trends: Wave Life Sciences Ltd. vs Amphastar Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Wave Life Sciences Ltd. and Galapagos NV
Cost of Revenue: Key Insights for Wave Life Sciences Ltd. and Evotec SE